• Publications
  • Influence
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.
CONTEXT Guidelines recommend that exercise training be considered for medically stable outpatients with heart failure. Previous studies have not had adequate statistical power to measure the effectsExpand
  • 1,400
  • 55
  • PDF
Muscle performance and enzymatic adaptations to sprint interval training.
Our purpose was to examine the effects of sprint interval training on muscle glycolytic and oxidative enzyme activity and exercise performance. Twelve healthy men (22 +/- 2 yr of age) underwentExpand
  • 439
  • 47
  • PDF
Irbesartan in patients with heart failure and preserved ejection fraction.
BACKGROUND Approximately 50% of patients with heart failure have a left ventricular ejection fraction of at least 45%, but no therapies have been shown to improve the outcome of these patients.Expand
  • 1,454
  • 46
  • PDF
Factors affecting blood pressure during heavy weight lifting and static contractions.
Brachial arterial pressure was directly recorded in 31 healthy male volunteers through protocols examining the effects of the Valsalva maneuver, muscle size and strength, contraction force,Expand
  • 224
  • 19
Low-volume, high-intensity interval training in patients with CAD.
PURPOSE Isocaloric interval exercise training programs have been shown to elicit improvements in numerous physiological indices in patients with CAD. Low-volume high-intensity interval exerciseExpand
  • 122
  • 18
  • PDF
Effects of exercise training in patients with heart failure: the Exercise Rehabilitation Trial (EXERT).
BACKGROUND The purpose of this study was to examine the effects of exercise training on functional capacity in patients with heart failure. METHODS One hundred eighty-one patients in New York HeartExpand
  • 328
  • 16
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
BACKGROUND Previous trials have shown that the use of statins to lower cholesterol reduces the risk of cardiovascular events among persons without cardiovascular disease. Those trials have involvedExpand
  • 421
  • 15
  • PDF
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management.
Heart failure remains a common diagnosis, especially in older individuals. It continues to be associated with significant morbidity and mortality, but major advances in both diagnosis and managementExpand
  • 434
  • 15
  • PDF
Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction
Background— The purpose of this study was to examine the prevalence of abnormalities in cardiac structure and function present in patients with heart failure and a preserved ejection fraction (HFPEF)Expand
  • 341
  • 13
  • PDF
Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot
BACKGROUND We investigated the effects of candesartan (an angiotensin II antagonist) alone, enalapril alone, and their combination on exercise tolerance, ventricular function, quality of life (QOL),Expand
  • 887
  • 12
  • PDF